Intraperitoneal Hydrocortisone for Postoperative Pain and CRP after Cesarean Section: A Randomized Controlled Trial
Natural Resources for Human Health · 05.10.2026 · 6 (20s) · 1501-1509
DOI: 10.53365/nrfhh.4295 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Natural Resources for Human Health, online erschienen am 05.10.2026. Verfasst von Raditsya Mada Gautama.
Themen: Schmerzmanagement
Abstract (Originalsprache)
Background
Postoperative pain and acute surgical peritoneal injury following cesarean section (CS) induce substantial local nociception and systemic inflammatory surges. Intraperitoneal instillation of hydrocortisone—an endogenous mammalian glucocorticoid—exerts anti-inflammatory properties, but its incremental clinical utility within an already optimized modern multimodal analgesia (MMA) regimen remains undefined.
Methods
In a prospective, double-blind, parallel-group, randomized controlled trial (ClinicalTrials.gov Identifier: NCT07892547), 50 parturients undergoing elective CS under spinal anesthesia (12.5 mg hyperbaric bupivacaine 0.5% + 50 µg intrathecal morphine), bilateral ultrasound-guided transversus abdominis plane (TAP) blocks (50 mg levobupivacaine per side), and 1 g intravenous paracetamol were randomized 1:1 using computer-generated permuted blocks with sequentially numbered opaque sealed envelopes. Following uterine repair, subjects received either 100 mg hydrocortisone in 100 mL 0.9% NaCl (Group H, n=25) or 100 mL 0.9% NaCl placebo (Group P, n=25) instilled into the peritoneal cavity. Primary outcome was Visual Analog Scale (VAS) pain intensity at 6, 12, and 24 hours. Secondary outcomes included serum C-reactive protein (CRP) concentrations (baseline, 12h, 24h), dynamic changes (ΔVAS, ΔCRP), rescue fentanyl consumption, and safety parameters.
Results
All 50 randomized subjects completed the 24-hour protocol without dropout. VAS pain scores did not differ significantly between Group H and Group P at 6 hours (3.04±0.98 vs. 3.04±0.20 cm; p=0.324), 12 hours (2.80±0.41 vs. 3.00±0.87 cm; p=0.611), or 24 hours (3.20±0.82 vs. 3.48±1.50 cm; p=1.000). Serum CRP concentrations increased significantly over time in both cohorts (Friedman p
Zitieren
APA
Gautama, R. M. (2026). Intraperitoneal Hydrocortisone for Postoperative Pain and CRP after Cesarean Section: A Randomized Controlled Trial. Natural Resources for Human Health, 6(20s), 1501-1509. https://doi.org/10.53365/nrfhh.4295
Vancouver
Gautama RM. Intraperitoneal Hydrocortisone for Postoperative Pain and CRP after Cesarean Section: A Randomized Controlled Trial. Natural Resources for Human Health. 2026;6(20s):1501-1509. doi:10.53365/nrfhh.4295
BibTeX
@article{Gautama2026,
author = {Gautama, Raditsya Mada},
title = {Intraperitoneal Hydrocortisone for Postoperative Pain and CRP after Cesarean Section: A Randomized Controlled Trial},
journal = {Natural Resources for Human Health},
year = {2026},
volume = {6},
number = {20s},
pages = {1501--1509},
doi = {10.53365/nrfhh.4295}
}
EUVIMED